Skip to content

Nimodipine

Published: July 26, 2026Updated: July 26, 2026

Nymalize is a brand-name calcium channel blocker available as an oral solution formulation. It is primarily prescribed to reduce the risk of cerebral ischemia and neurological complications following subarachnoid hemorrhage (SAH). The liquid formulation is particularly useful for patients who have difficulty swallowing tablets following this type of brain bleed.

Quick summary

Nymalize is a calcium channel blocker used to prevent neurological complications after brain bleeding (subarachnoid hemorrhage).

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
1423768
Generic
Nymalize
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Nymalize is indicated for the treatment of subarachnoid hemorrhage (SAH) to reduce the incidence and severity of ischemic neurological deficits resulting from cerebral vasospasm in adult patients.

Nymalize contains nimodipine, a dihydropyridine calcium channel blocker that preferentially acts on cerebral blood vessels. It causes smooth muscle relaxation and vasodilation of cerebral arteries, which helps improve blood flow to the brain and may reduce the risk of vasospasm-related complications following SAH.

Nymalize should be administered via the oral route (with or without food); the oral solution can be taken directly or mixed with water. It must not be administered intravenously or via nasogastric tubes. Blood pressure should be monitored during treatment as significant hypotension may occur. Concurrent use with grapefruit juice should be avoided as it may increase drug bioavailability.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy